New York State Common Retirement Fund’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165K | Hold |
13,746
| – | – | ﹤0.01% | 2446 |
|
|
2026
Q1 | $115K | Hold |
13,746
| – | – | ﹤0.01% | 2459 |
|
|
2025
Q4 | $198K | Hold |
13,746
| – | – | ﹤0.01% | 2305 |
|
|
2025
Q3 | $133K | Hold |
13,746
| – | – | ﹤0.01% | 2482 |
|
|
2025
Q2 | $113K | Hold |
13,746
| – | – | ﹤0.01% | 2507 |
|
|
2025
Q1 | $98.3K | Hold |
13,746
| – | – | ﹤0.01% | 2526 |
|
|
2024
Q4 | $106K | Sell |
13,746
-2,900
| -17% | -$27.2K | ﹤0.01% | 2564 |
|
|
2024
Q3 | $175K | Hold |
16,646
| – | – | ﹤0.01% | 2362 |
|
|
2024
Q2 | $195K | Buy |
16,646
+346
| +2% | +$5.38K | ﹤0.01% | 2437 |
|
|
2024
Q1 | $343K | Hold |
16,300
| – | – | ﹤0.01% | 2221 |
|
|
2023
Q4 | $293K | Sell |
16,300
-427
| -3% | -$7.52K | ﹤0.01% | 2302 |
|
|
2023
Q3 | $275K | Buy |
16,727
+128
| +0.8% | +$2.32K | ﹤0.01% | 2286 |
|
|
2023
Q2 | $332K | Sell |
16,599
-7,536
| -31% | -$145K | ﹤0.01% | 2279 |
|
|
2023
Q1 | $456K | Sell |
24,135
-4,307
| -15% | -$95.3K | ﹤0.01% | 2223 |
|
|
2022
Q4 | $645K | Sell |
28,442
-15
| -0.1% | -$339 | ﹤0.01% | 2192 |
|
|
2022
Q3 | $752K | Buy |
28,457
+51
| +0.2% | +$1.51K | ﹤0.01% | 2119 |
|
|
2022
Q2 | $702K | Sell |
28,406
-46
| -0.2% | -$1.15K | ﹤0.01% | 2191 |
|
|
2022
Q1 | $944K | Sell |
28,452
-14
| -0% | -$389 | ﹤0.01% | 2134 |
|
|
2021
Q4 | $931K | Sell |
28,466
-60
| -0.2% | -$2.04K | ﹤0.01% | 2136 |
|
|
2021
Q3 | $1.2M | Sell |
28,526
-7,292
| -20% | -$262K | ﹤0.01% | 2036 |
|
|
2021
Q2 | $1.39M | Buy |
35,818
+5,418
| +18% | +$194K | ﹤0.01% | 2063 |
|
|
2021
Q1 | $1.04M | Hold |
30,400
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q4 | $1.38M | Sell |
30,400
-2,300
| -7% | -$80.4K | ﹤0.01% | 1883 |
|
|
2020
Q3 | $900K | Hold |
32,700
| – | – | ﹤0.01% | 1963 |
|
|
2020
Q2 | $1.2M | Buy |
32,700
+2,700
| +9% | +$101K | ﹤0.01% | 1771 |
|
|
2020
Q1 | $971K | Hold |
30,000
| – | – | ﹤0.01% | 1743 |
|
|
2019
Q4 | $1.23M | Sell |
30,000
-4,600
| -13% | -$182K | ﹤0.01% | 1854 |
|
|
2019
Q3 | $1.23M | Hold |
34,600
| – | – | ﹤0.01% | 1896 |
|
|
2019
Q2 | $1.78M | Sell |
34,600
-5,542
| -14% | -$277K | ﹤0.01% | 1716 |
|
|
2019
Q1 | $2.3M | Buy |
40,142
+4,171
| +12% | +$207K | ﹤0.01% | 1548 |
|
|
2018
Q4 | $1.51M | Sell |
35,971
-3,014
| -8% | -$177K | ﹤0.01% | 1692 |
|
|
2018
Q3 | $2.94M | Buy |
38,985
+7,185
| +23% | +$518K | ﹤0.01% | 1482 |
|
|
2018
Q2 | $2.28M | Buy |
31,800
+1,900
| +6% | +$90.7K | ﹤0.01% | 1618 |
|
|
2018
Q1 | $893K | Hold |
29,900
| – | – | ﹤0.01% | 2088 |
|
|
2017
Q4 | $994K | Hold |
29,900
| – | – | ﹤0.01% | 2039 |
|
|
2017
Q3 | $985K | Hold |
29,900
| – | – | ﹤0.01% | 2013 |
|
|
2017
Q2 | $591K | Buy |
29,900
+8,999
| +43% | +$174K | ﹤0.01% | 2328 |
|
|
2017
Q1 | $403K | Sell |
20,901
-6,794
| -25% | -$131K | ﹤0.01% | 2485 |
|
|
2016
Q4 | $514K | Buy |
27,695
+6,795
| +33% | +$130K | ﹤0.01% | 2355 |
|
|
2016
Q3 | $293K | Hold |
20,900
| – | – | ﹤0.01% | 2592 |
|
|
2016
Q2 | $167K | Buy |
20,900
+14,100
| +207% | +$156K | ﹤0.01% | 2815 |
|
|
2016
Q1 | $73K | Buy |
+6,800
| New | +$87K | ﹤0.01% | 2996 |
|
Other funds holding RGNX
YIH
New York State Common Retirement Fund's RGNX Position: Q2 2026 in Review
New York State Common Retirement Fund held its Regenxbio (RGNX) position steady in Q2 2026 at 13,746 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.
New York State Common Retirement Fund first reported a position in RGNX in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.94M in Q3 2018. 52 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- New York State Common Retirement Fund held 13,746 shares of Regenxbio worth $165K as of Q2 2026.
- New York State Common Retirement Fund left its Regenxbio share count unchanged in Q2 2026.
- Regenxbio made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2446 holding.
- New York State Common Retirement Fund first reported a position in Regenxbio in Q1 2016 and has held it in 42 quarters since.
- New York State Common Retirement Fund's Regenxbio position peaked at $2.94M in Q3 2018.
- 52 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.